The French EsoGastricTumours Data Base
ConditionEsophageal Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorUniversity Hospital, Lille
About this trial
This retrospective study aims at evaluating the outcomes of gastrointestinal stromal tumor after surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
esophageal cancer, gastric or gastroesophageal junction diagnosed biopsy , regardless of the subtype of cancer, tumor stage or treatment envisaged.
Naive treatment for this cancer,
Naive treatment for this cancer , failing that received neoadjuvant treatment ,
Male or female ≥ 18 years.
Disqualifiers
Private person of liberty or under supervision (including guardianship ) .
People who do not speak French.
Major Nobody unable to consent .
Patient FREGAT already included in the base.
Trial population
All patients with gastroesophageal cancer diagnosed and treatment-naïve, if not receiving neoadjuvant treatment in a participating center will be included after acceptance and signature of consent, whether operated or not, whatever histologic type, tumor stage, and the therapeutic strategy.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
DIsease free survival
Time frame
5 year disease free survivalSecondary outcomes
1
overall survival
Time frame
5 year overall survival2
recurrence rate
Time frame
5 year recurrence rate3
Total number of patients with complications
Time frame
from the time between inclusion and occurrence of the event, for the duration of 3 years4
Total number of complications
Time frame
from the time between inclusion and occurrence of the event, for the duration of 3 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University Hospital, Lille
Lead sponsor
French Eso-Gastric Tumors Working Group
Collaborator
National Cancer Institute, France
Collaborator
Source ClinicalTrials.gov